| Separate and combined glucometabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals LS Gasbjerg, MM Helsted, B Hartmann, MH Jensen, MBN Gabe, ... Diabetes 68 (5), 906-917, 2019 | 143 | 2019 |
| Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists LS Gasbjerg, NC Bergmann, S Stensen, MB Christensen, MM Rosenkilde, ... Peptides 125, 170183, 2020 | 82 | 2020 |
| Factors associated with type‐specific persistence of high‐risk human papillomavirus infection: a population‐based study S Stensen, SK Kjaer, SM Jensen, K Frederiksen, J Junge, T Iftner, C Munk International journal of cancer 138 (2), 361-368, 2016 | 62 | 2016 |
| GIP and GLP-1 receptor antagonism during a meal in healthy individuals LS Gasbjerg, MM Helsted, B Hartmann, AH Sparre-Ulrich, S Veedfald, ... The Journal of Clinical Endocrinology & Metabolism 105 (3), e725-e738, 2020 | 45 | 2020 |
| The role of endogenous GIP and GLP-1 in postprandial bone homeostasis MM Helsted, LS Gasbjerg, AR Lanng, NC Bergmann, S Stensen, ... Bone 140, 115553, 2020 | 31 | 2020 |
| GIP and the gut-bone axis–Physiological, pathophysiological and potential therapeutic implications S Stensen, LS Gasbjerg, MM Helsted, B Hartmann, MB Christensen, ... Peptides 125, 170197, 2020 | 29 | 2020 |
| Effects of endogenous GIP in patients with type 2 diabetes S Stensen, LS Gasbjerg, LL Krogh, K Skov-Jeppesen, AH Sparre-Ulrich, ... European Journal of Endocrinology 185 (1), 33-45, 2021 | 28 | 2021 |
| The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes NB Dalsgaard, LS Gasbjerg, LS Hansen, NL Hansen, S Stensen, ... European Journal of Endocrinology 184 (3), 383-394, 2021 | 21 | 2021 |
| GIP’s involvement in the pathophysiology of type 2 diabetes MB Christensen, LS Gasbjerg, SM Heimbürger, S Stensen, T Vilsbøll, ... Peptides 125, 170178, 2020 | 21 | 2020 |
| Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH2 on GIP actions in humans LS Gasbjerg, EJ Bari, S Stensen, B Hoe, AR Lanng, DS Mathiesen, ... Diabetes, Obesity and Metabolism 23 (1), 68-74, 2021 | 20 | 2021 |
| Awareness of human papillomavirus after introduction of HPV vaccination: a large population-based survey of Scandinavian women LT Thomsen, M Nygård, S Stensen, BT Hansen, LA Dahlström, KL Liaw, ... European Journal of Cancer Prevention 26 (2), 170-178, 2017 | 14 | 2017 |
| 64-OR: postprandial effects of endogenous glucose-dependent insulinotropic polypeptide in type 2 diabetes S Stensen, LS Gasbjerg, LS Krogh, AH Sparre-Ulrich, K Skov-Jeppesen, ... Diabetes 68 (Supplement_1), 2019 | 10 | 2019 |
| Endogenous glucose-dependent insulinotropic polypeptide contributes to sitagliptin-mediated improvement in β-cell function in patients with type 2 diabetes S Stensen, LS Gasbjerg, MM Rosenkilde, T Vilsbøll, JJ Holst, B Hartmann, ... Diabetes 71 (10), 2209-2221, 2022 | 7 | 2022 |
| Acute concomitant glucose‐dependent insulinotropic polypeptide receptor antagonism during glucagon‐like peptide 1 receptor agonism does not affect appetite, resting energy … S Stensen, LL Krogh, AH Sparre‐Ulrich, F Dela, B Hartmann, T Vilsbøll, ... Diabetes, Obesity and Metabolism 24 (9), 1882-1887, 2022 | 5 | 2022 |
| The role of the incretins in the postprandial bone remodelling MM Helsted, LS Gasbjerg, AR Lanng, S Stensen, B Hartmann, ... Diabetologia 61 (Suppl 1), S221-S221, 2018 | 4 | 2018 |
| Postprandial effects of individual and combined GIP and GLP-1 receptor antagonization in healthy subjects LS Gasbjerg, MM Helsted, AH Sparre-Ulrich, AR Lanng, S Stensen, ... Diabetes 67 (Supplement_1), 2018 | 3 | 2018 |
| The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans LSL Krogh, K Henriksen, S Stensen, K Skov-Jeppesen, NC Bergmann, ... European Journal of Endocrinology 188 (1), 48-58, 2023 | 2 | 2023 |
| 357-OR: Improved Glycemic Control in Persons with Type 2 Diabetes Improves Beta-Cell Actions of Endogenous Glucose-Dependent Insulinotropic Polypeptide B HOE, MB Lynggaard, LS Gasbjerg, MM Helsted, S Stensen, ... Diabetes 71 (Supplement_1), 2022 | 2 | 2022 |
| 1145-P: Acarbose-Induced Glucagon-Like Peptide-1 Secretion Contributes to the Glucose-Lowering Effect of Acarbose NB Dalsgaard, LS Gasbjerg, LS Hansen, NL Hansen, S Stensen, ... Diabetes 68 (Supplement_1), 2019 | 2 | 2019 |
| Postprandial effects of individual and combined GIP and GLP-1 receptor antagonism in healthy subjects LS Gasbjerg, MM Helsted, AH Sparre-Ulrich, AR Lanng, S Stensen, ... Diabetologia 61 (suppl 1), S246-S246, 2018 | 2 | 2018 |
